Viridian Therapeutics, Inc. (VRDN)

Viridian Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	99.59	102.83	155.58	42.3	45.9
Short-Term Investments	617.99	374.54	268.97	154.67	81.74
Cash & Short-Term Investments	717.58	477.37	424.55	196.97	127.64
Cash Growth	50.32%	12.44%	115.55%	54.31%	375.47%
Receivables	-	0.1	0.1	0.45	-
Prepaid Expenses	20.88	9.01	6.52	2.65	1.97
Other Current Assets	-	-	-	0.1	-
Total Current Assets	738.46	486.48	431.17	200.16	129.61
Property, Plant & Equipment	3.44	3.34	2.94	2.06	0.79
Other Long-Term Assets	0.5	0.6	0.98	1.49	0.86
Total Assets	742.4	490.42	435.09	203.71	131.26
Accounts Payable	2.14	2.24	14.23	2.33	0.67
Accrued Expenses	44.83	23.17	18.11	10.4	9.06
Current Portion of Leases	0.51	0.84	0.61	0.52	0.46
Current Unearned Revenue	0.29	0.29	0.29	0.29	0.3
Other Current Liabilities	0.1	0.1	0.1	0.1	0.19
Total Current Liabilities	47.87	26.64	33.35	13.64	10.67
Long-Term Debt	20.58	20.21	4.65	-	-
Long-Term Leases	2.02	0.99	-	-	-
Long-Term Unearned Revenue	0.28	0.57	0.86	1.15	-
Other Long-Term Liabilities	-	-	1.17	1.21	0.54
Total Liabilities	70.76	48.4	40.03	15.99	11.22
Common Stock	0.81	0.54	0.41	0.24	0.04
Additional Paid-In Capital	1,478	960.54	741.07	412.1	218.09
Retained Earnings	-995.86	-725.91	-488.17	-358.3	-278.89
Comprehensive Income & Other	-0.01	0.34	-0.39	-0.16	-0.01
Total Common Equity	482.75	235.51	252.92	53.88	-60.76
Shareholders' Equity	671.64	442.02	395.06	187.72	120.04
Total Liabilities & Equity	742.4	490.42	435.09	203.71	131.26
Total Debt	23.12	22.04	5.26	0.52	0.46
Net Cash (Debt)	694.47	455.33	419.29	196.45	127.18
Net Cash Growth	52.52%	8.60%	113.44%	54.46%	585.96%
Net Cash Per Share	10.23	10.17	13.07	16.48	35.76
Filing Date Shares Outstanding	81.48	62.77	42.9	25.91	7.23
Total Common Shares Outstanding	80.99	53.99	41.31	23.92	4.23
Working Capital	690.59	459.84	397.82	186.53	118.94
Book Value Per Share	5.96	4.36	6.12	2.25	-14.36
Tangible Book Value	482.75	235.51	252.92	53.88	-60.76
Tangible Book Value Per Share	5.96	4.36	6.12	2.25	-14.36
Machinery	2.25	2.05	2.22	1.4	3.01
Leasehold Improvements	0.25	0.67	1.11	0.75	0.74

Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q